Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

ADIAL PHARMACEUTICALS, INC. (ADIL)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-23Sep-30-22Jun-30-22Mar-31-22Sep-30-21Jun-30-21Mar-31-21Dec-31-20
   10-Q10-Q10-Q10-Q10-Q10-Q10-Q10-K
Research and development expenses      8.18.36.95.9
General and administrative expenses         5.1
    Total Operating Expenses      16.816.113.510.9
    Loss From Operations      -16.8-16.1-13.5-10.9
Interest income      0.00.0 0.0
    Total other income (expense)      -0.30.00.00.0
Income (Loss) Before Provision For Income Taxes      -17.1-16.1-13.4-10.9
   
Provision for income taxes          
    Net Income (Loss)      -17.1-16.1-13.4-10.9
   
Net income (loss) per share, basic and diluted (in Dollars per share)      ($1.01)($1.03)($0.94)($0.86)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy